Navigation Links
Pyratine-6(TM) Study Published in Journal of Drugs in Dermatology
Date:2/26/2008

matopharmacology. During his academic career he has effectively combined his expertise in pharmacology to the basic and clinical areas of dermatology. His work in dermatopharmacology has focused on the skin barrier properties and topical delivery of drugs. He has worked extensively with pharmaceutical companies in the development of effective topical drug delivery systems and has written over 40 IND applications for testing new topical therapies for skin disorders. His work is unique, in that drug development is taken from formulation testing in vitro to studies in experimental models, and finally to clinical testing in patients.

Dr. McCullough joined the faculty of the Department of Dermatology of the University of California, Irvine School of Medicine in 1979, where he is currently a Professor of Dermatology and Director of the Dermatology Clinical Research Center. Dr. McCullough earned his Bachelor of Science degree in chemistry from Indiana University and his Ph.D. in pharmacology from Yale University.

About Senetek PLC

Senetek PLC (OTCBB: SNKTY) is a Life Sciences company engaged in the development of breakthrough technologies that target the science of healthy aging. The Company's extensive research collaborations have resulted in a strong pipeline of patented compounds and products with broad therapeutic applications and a leading presence in dermatology. Senetek collaborates with established specialty pharmaceutical companies in the final development and marketing of its proprietary products, most recently resulting in the development of the best-selling anti-aging product sold in the North American physician market.

For more information, visit the company's website at http://www.senetekplc.com.

This news release contains statements that may be considered 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act. Forward-looking stat
'/>"/>

SOURCE Senetek PLC
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Dr. Mark Nestor Presents on Pyratine-6(TM) at the South Beach Symposium
2. BSPs New Line of HyperQ Products: Bedside Ischemia Monitoring Systems Announces Successful Results of First Feasibility Study
3. Idenix Announces Data Presentations at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL)
4. New Independent Research Study Indicates That Cylexs ImmuKnow Test May Identify Kidney Transplant Patients at Risk for Early Acute Rejection
5. New Technology for Early Detection of Lung Cancer Selected for Clinical Study With Veterans
6. Biomoda and Medical Acoustics Partner in Study for Early Detection of Lung Cancer in Veterans
7. Study by Leading Economist Identifies Potential for $378 Billion of Savings From Follow On Biologics
8. Pharmaceutical Budget and Staffing: Powerful New Metrics-Based Study
9. Forest Laboratories, Inc. Announces Positive Results of Memantine Study of Once-Daily Formulation
10. Epistem plc and AstraZeneca Complete Plucked Hair Biomarker Study for Oncology Drug Development
11. Statement by John Bailey, Chief Scientist: The Personal Care Products Council Response to Study on Phthalate Exposure in Baby Care Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... conducted pursuant to Special Protocol Assessment with ... CITY, Dec. 16 /PRNewswire-FirstCall/ - AEterna Zentaris ... (the "Company"), a global biopharmaceutical company focused ... the initiation, by its partner Keryx Biopharmaceuticals ... 3 registration clinical trial for perifosine (KRX-0401), ...
(Date:12/15/2009)... Epeius Biotechnologies Corporation, an emerging leader ... international validation of the cutting-edge science behind its ... around the world rediscovered the Cyclin G1 ... cancer pathogenesis and disease progression, and thus a ... the NIH National Cancer Institute investigating the role ...
(Date:12/15/2009)... -- Aethlon Medical, Inc. (OTC Bulletin Board : ... Dr. Wayne Comper have joined the ... Both Dr. Schorey and Dr. Comper are leading ... owned subsidiary of Aethlon Medical, was recently formed ... medical device being advanced as an adjunct therapy ...
(Date:12/15/2009)... 15 The Center for Business ... is pleased to announce the full agenda ... and Reporting Congress . The forum will ... March 16-17, 2010. ,, Over 1,500 senior-level ... attended this premier event since its inception, ...
Breaking Biology Technology:AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 2Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 4Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 5CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress 2
... (Nasdaq:,AMGN) today announced that it plans to report its ... the close of the financial,markets. The announcement will be ... 1:30 p.m. Pacific Time. Participating in the call,from Amgen ... members of,Amgen,s senior management team., Live audio of ...
... industry,and government leaders gathered in Kannapolis, Monday, October ... House celebration for the David H. Murdock,Core Laboratory ... NC,State Fruit and Vegetable Science Institute Building. The ... University, NC Central University, UNC,Chapel Hill and UNC ...
... its newest tenant partner. The NC Research Campus is the vision ... colleges (including Duke University, UNC, and NC State)will have research units located ... to be a world class center for industry and academic research for ... ...
Other Biology Technology:Amgen Announces Webcast of 2008 Third Quarter Financial Results 2Campus Celebrates Historic Milestone 2Campus Celebrates Historic Milestone 3Campus Celebrates Historic Milestone 4Campus Celebrates Historic Milestone 5Food and Beverage Giant Joins Kannapolis Research Center 2Food and Beverage Giant Joins Kannapolis Research Center 3Food and Beverage Giant Joins Kannapolis Research Center 4
(Date:12/16/2009)... researcher will lead the coordinating center for a consortium ... of stem cell research. Michael L. Terrin, M.D.,C.M.,M.P.H., professor ... National Heart, Lung and Blood Institute (NHLBI) to coordinate ... will be called the NHLBI Progenitor Cell Biology Consortium. ... million grant over seven years. , ...
(Date:12/16/2009)... 2 DigitalPersona, Inc., a leader ... announced an agreement with IBM to deploy ... fingerprint technology on IBM SurePOS 500 retail ... point-of-sale applications to more easily and quickly ... be linked to the individuals who perform ...
(Date:12/16/2009)... Solutions Inc. is pleased to announce it has ... previously operating as IgeaCare Systems Inc. The newly ... new leadership and funding. ,, IgeaCare Solutions Inc. ... of Chief Executive Officer. Under his direction, the ... servicing and support model; fast and accurate delivery ...
Breaking Biology News(10 mins):University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 3DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems 2IgeaCare Solutions Inc. Emerges Under New Leadership and Funding 2New Data Shows Obesity Costs Will Grow to 24344 Billion by 2018 61483 1New Data Shows Obesity Costs Will Grow to 24344 Billion by 2018 61483 2New Data Shows Obesity Costs Will Grow to 24344 Billion by 2018 61483 3New Data Shows Obesity Costs Will Grow to 24344 Billion by 2018 61483 4deCODE genetics Inc Files Voluntary Chapter 11 Petition to Facilitate Sale of Assets 6316 1deCODE genetics Inc Files Voluntary Chapter 11 Petition to Facilitate Sale of Assets 6316 2deCODE genetics Inc Files Voluntary Chapter 11 Petition to Facilitate Sale of Assets 6316 3deCODE genetics Inc Files Voluntary Chapter 11 Petition to Facilitate Sale of Assets 6316 4Coed college housing connected to frequent binge drinking 61480 1Coed college housing connected to frequent binge drinking 61480 2
... N.Y., JAN. 9, 2008 Not enough American women ... day can help prevent serious birth defects, and only ... essential nutrient beginning before pregnancy, two recent surveys show. ... beginning before pregnancy is crucial because birth defects of ...
... at MIT are developing a tiny sensor that could ... including toxic industrial chemicals and chemical warfare agents, much ... taken the common techniques of gas chromatography and mass ... the size of a computer mouse. Eventually, the team, ...
... Cancer patients usually ask what can be done after ... organs. In many cases, they learn, little can be done. ... Spring Harbor Laboratory (CSHL) of a type of cell that ... aggressive metastases the kind that kill cancer patients. ...
Other Biology News:New folic acid seal helps women choose enriched grain foods to help prevent birth defects 2New folic acid seal helps women choose enriched grain foods to help prevent birth defects 3MIT gas sensor is tiny, quick 2CSHL scientists identify cells that promote formation of lethal lung metastases 2
... expression of an N-terminal FLAG® fusion and ... marker from bicistronic mRNA. Two genes ... for transcription of a single message from ... for protein-protein interaction studies, multi-subunit proteins, and ...
Mouse monoclonal antibody raised against a partial recombinant CALCOCO2. NCBI Entrez Gene ID = CALCOCO2...
Mouse polyclonal antibody raised against a partial recombinant KCTD13. NCBI Entrez Gene ID = 253980...
... is a direct antibiotic-based selection system for ... colony survival, eliminating the need for costly ... provides close to 100% accuracy in recombinant ... for robot colony picking. This cloning ...
Biology Products: